<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8816450" created="22/11/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8816450</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Analysis of the <term id="T1" lex="ligand-binding_domain" sem="Protein_domain_or_region"><term id="A1" sem="Protein_family_or_group">ligand</term>-binding domain</term> of <term id="T2" lex="human_retinoic_acid_receptor_alpha" sem="Protein_molecule">human retinoic acid receptor alpha</term> by <term id="T3" lex="site-directed_mutagenesis" sem="Other">site-directed mutagenesis</term>.</sentence>
<event KT="Investigation" id="E1" uncertainty="doubtful">
<type class="Binding"/>
<theme idref="A1"/>
<theme idref="T2"/>
<clue><clueKT>Analysis</clueKT> of the ligand-<clueType>binding</clueType> domain of human retinoic acid receptor alpha <clueExperiment>by site-directed mutagenesis.</clueExperiment></clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Three subtypes of <term id="T4" lex="retinoic_acid_receptor" sem="Protein_family_or_group"><term id="T5" lex="retinoic_acid" sem="Organic_compound_other">retinoic acid</term> receptors</term> (<term id="T6" lex="RAR" sem="Protein_family_or_group">RAR</term>), termed <term id="T7" lex="RAR_alpha" sem="Protein_molecule">RAR alpha</term>, <term id="T8" lex="RAR_beta" sem="Protein_molecule">RAR beta</term>, and <term id="T9" lex="RAR_gamma" sem="Protein_molecule">RAR gamma</term>, have been described.</sentence>
<sentence id="S3">They are composed of different <term id="T10" lex="structural_domain" sem="Protein_domain_or_region">structural domains</term>, including distinct domains for <term id="A2" sem="DNA_molecule">DNA</term> and <term id="A3" sem="Protein_molecule">ligand</term> binding.</sentence>
<event KT="Other" id="E2">
<type class="Binding"/>
<theme idref="T10"/>
<theme idref="A2"/>
<clue>They are composed of different structural domains, including distinct domains for DNA and ligand <clueType>binding</clueType>.</clue>
</event>
<event KT="Other" id="E3">
<type class="Binding"/>
<theme idref="T10"/>
<theme idref="A3"/>
<clue>They are composed of different structural domains, including distinct domains for DNA and ligand <clueType>binding</clueType>.</clue>
</event>
<sentence id="S4"><term id="T11" lex="RAR" sem="Protein_family_or_group">RARs</term> specifically bind <term id="T12" lex="all-trans-retinoic_acid" sem="Organic_compound_other">all-trans-retinoic acid</term> (<term id="T13" lex="RA" sem="Organic_compound_other">RA</term>), <term id="T14" lex="9-cis-RA" sem="Organic_compound_other">9-cis-RA</term>, and <term id="T15" lex="retinoid_analog" sem="Organic_compound_other">retinoid analogs</term>.</sentence>
<event KT="Fact" id="E4">
<type class="Binding"/>
<theme idref="T11"/>
<theme idref="T13"/>
<clue>RARs specifically <clueType>bind</clueType> all-trans-retinoic acid (RA), 9-cis-RA, and retinoid analogs.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Binding"/>
<theme idref="T11"/>
<theme idref="T14"/>
<clue>RARs specifically <clueType>bind</clueType> all-trans-retinoic acid (RA), 9-cis-RA, and retinoid analogs.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Binding"/>
<theme idref="T11"/>
<theme idref="T15"/>
<clue>RARs specifically <clueType>bind</clueType> all-trans-retinoic acid (RA), 9-cis-RA, and retinoid analogs.</clue>
</event>
<sentence id="S5">In this study, we examined the functional role of <term id="T16" lex="cysteine" sem="Amino_acid_monomer">cysteine</term> and <term id="A6" sem="Amino_acid_monomer">arginine</term> <term id="A7" sem="Amino_acid_monomer">residues in the <term id="T17" lex="ligand-binding_domain" sem="Protein_domain_or_region">ligand-binding domain</term></term> of <term id="T18" lex="hRAR_alpha" sem="Protein_molecule">hRAR alpha</term> (<term id="T19" lex="hRAR_alpha-LBD" sem="Protein_molecule">hRAR alpha-LBD</term>, <term id="T20" lex="amino_acids_154_to_462" sem="Protein_domain_or_region">amino acids 154 to 462</term>).</sentence>
<event KT="Investigation" id="E9" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T19"/>
<cause idref="T16" idref1="A7"/>
<clue>In this study, we <clueKT>examined</clueKT> the functional <clueType>role</clueType> <linkCause>of</linkCause> cysteine and arginine residues in the ligand-binding domain of hRAR alpha (hRAR alpha-LBD, amino acids 154 to 462).</clue>
<comment>TPS: A7</comment></event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T19"/>
<cause idref="A6" idref1="A7"/>
<clue>In this study, we <clueKT>examined</clueKT> the functional <clueType>role</clueType> <linkCause>of</linkCause> cysteine and arginine residues in the ligand-binding domain of hRAR alpha (hRAR alpha-LBD, amino acids 154 to 462).</clue>
</event>
<sentence id="S6">All conserved <term id="T21" lex="cysteine" sem="Amino_acid_monomer">cysteine</term> and <term id="T22" lex="arginine_residue" sem="Amino_acid_monomer">arginine residues</term> in this domain were mutated by <term id="T55" sem="DNA_domain_or_region">site</term>-directed <term id="T23" sem="Other">mutagenesis</term>, and the <term id="T24" lex="mutant_protein" sem="Protein_family_or_group">mutant proteins</term> were characterized by <term id="T25" lex="blocking_reaction" sem="Other">blocking reactions</term>, <term id="T26" lex="ligand-binding_experiment" sem="Other"><term id="T56" sem="Protein_family_or_group">ligand</term>-binding experiments</term>, <term id="T27" lex="transactivation_assay" sem="Other">transactivation assays</term>, and <term id="T28" lex="protease_mapping" sem="Other"><term id="T29" lex="protease" sem="Protein_family_or_group">protease</term> mapping</term>.</sentence>
<sentence id="S7"><term id="T57" sem="Other">Changes</term> of any <term id="T30" sem="Amino_acid_monomer">cysteine residue</term> of the <term id="T31" lex="hRAR_alpha-LBD" sem="Protein_domain_or_region">hRAR alpha-LBD</term> had no significant influence on the <term id="T58" sem="Other">binding</term> of <term id="T32" lex="all-trans_RA" sem="Organic_compound_other">all-trans RA</term> or <term id="T33" lex="9-cis_RA" sem="Organic_compound_other">9-cis RA</term>.</sentence>
<event id="E13">
<type class="Mutagenesis"/>
<theme idref="T30"/>
<clue><clueType>Changes</clueType> <linkTheme>of</linkTheme> any cysteine residue <clueLoc>of the hRAR alpha-LBD</clueLoc> had no significant influence on the binding of all-trans RA or 9-cis RA.</clue>
<comment>Artificial</comment></event>
<event id="E14">
<type class="Binding"/>
<theme idref="T31"/>
<theme idref="T32"/>
<clue>Changes of any cysteine residue of the hRAR alpha-LBD had no significant influence on the <clueType>binding</clueType> <linkTheme>of</linkTheme> all-trans RA or 9-cis RA.</clue>
<comment>NER: T31 MOD</comment></event>
<event id="E15">
<type class="Binding"/>
<theme idref="T31"/>
<theme idref="T33"/>
<clue>Changes of any cysteine residue of the hRAR alpha-LBD had no significant influence on the <clueType>binding</clueType> <linkTheme>of</linkTheme> all-trans RA or 9-cis RA.</clue>
</event>
<event Manner="Low" assertion="non-exist" id="E16">
<type class="Regulation"/>
<theme idref="E14"/>
<cause idref="E13"/>
<clue>Changes of any cysteine residue of the hRAR alpha-LBD had <clueManner>no significant</clueManner> <clueType>influence</clueType> <linkTheme>on</linkTheme> the binding of all-trans RA or 9-cis RA.</clue>
</event>
<event Manner="Low" assertion="non-exist" id="E17">
<type class="Regulation"/>
<theme idref="E15"/>
<cause idref="E13"/>
<clue>Changes of any cysteine residue of the hRAR alpha-LBD had <clueManner>no significant</clueManner> <clueType>influence</clueType> <linkTheme>on</linkTheme> the binding of all-trans RA or 9-cis RA.</clue>
</event>
<sentence id="S8">Interestingly, <term id="T34" lex="residue_C-235" sem="Amino_acid_monomer">residue C-235</term> is specifically important in <term id="T35" sem="Other"><term id="A8" sem="Other">antagonist</term> binding</term>.</sentence>
<event id="E18">
<type class="Binding"/>
<theme idref="A8"/>
<theme idref="T31"/>
<clue>Interestingly, residue C-235 is specifically important in antagonist <clueType>binding</clueType>.</clue>
<comment>NO COREFTHEME, OK</comment></event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="T34"/>
<clue>Interestingly, residue C-235 is specifically <clueType>important</clueType> <linkTheme>in</linkTheme> antagonist binding.</clue>
</event>
<sentence id="S9">With respect to <term id="T36" lex="arginine_residue" sem="Amino_acid_monomer">arginine residues</term>, only the two <term id="T37" lex="single_mutation" sem="Other">single mutations</term> of <term id="T38" lex="R-276" sem="Amino_acid_monomer">R-276</term> and <term id="T39" lex="R-394" sem="Amino_acid_monomer">R-394</term> to <term id="T40" lex="alanine" sem="Amino_acid_monomer">alanine</term> showed a dramatic decrease of <cons id="C1" lex="(AND agonist_binding antagonist_binding)" sem="(AND Other Other)"><frag id="F1">agonist</frag> and <frag id="F2">antagonist</frag> <frag id="F3">binding</frag></cons> whereas the <term id="T41" lex="R272A_mutation" sem="Other"><term id="T42" lex="R272A" sem="Amino_acid_monomer">R272A</term> mutation</term> showed only a slight effect.</sentence>
<event KT="Other" id="E20">
<type class="Binding"/>
<theme idref="T31"/>
<theme idref="F1"/>
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist <clueType>binding</clueType> whereas the R272A mutation showed only a slight effect.</clue>
<comment>NO COREFTHEME</comment></event>
<event KT="Other" id="E21">
<type class="Binding"/>
<theme idref="T31"/>
<theme idref="F2"/>
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist <clueType>binding</clueType> whereas the R272A mutation showed only a slight effect.</clue>
<comment>NO COREFTHEME</comment></event>
<event KT="Other" id="E22">
<type class="Mutagenesis"/>
<theme idref="T38"/>
<clue>With respect to arginine residues, only the two <clueType>single mutations</clueType> <linkTheme>of</linkTheme> R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
<comment>Artificial</comment></event>
<event KT="Other" id="E23">
<type class="Mutagenesis"/>
<theme idref="T39"/>
<clue>With respect to arginine residues, only the two <clueType>single mutations</clueType> <linkTheme>of</linkTheme> R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
<comment>Artificial</comment></event>
<event KT="Analysis" Manner="High" id="E24">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="E22"/>
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine <clueKT>showed</clueKT> a <clueManner>dramatic</clueManner> <clueType>decrease</clueType> <linkTheme>of</linkTheme> agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
</event>
<event KT="Analysis" Manner="High" id="E25">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="E22"/>
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine <clueKT>showed</clueKT> a <clueManner>dramatic</clueManner> <clueType>decrease</clueType> <linkTheme>of</linkTheme> agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
</event>
<event KT="Analysis" Manner="High" id="E26">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="E23"/>
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine <clueKT>showed</clueKT> a <clueManner>dramatic</clueManner> <clueType>decrease</clueType> <linkTheme>of</linkTheme> agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
</event>
<event KT="Analysis" Manner="High" id="E27">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="E23"/>
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine <clueKT>showed</clueKT> a <clueManner>dramatic</clueManner> <clueType>decrease</clueType> <linkTheme>of</linkTheme> agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
</event>
<event KT="Method" id="E28">
<type class="Mutagenesis"/>
<theme idref="T42"/>
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A <clueType>mutation</clueType> showed only a slight effect.</clue>
<comment>Artificial</comment></event>
<event KT="Analysis" Manner="Low" assertion="non-exist" id="E29">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="E28"/>
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A mutation <clueKT>showed</clueKT> <clueType>only a <clueManner>slight</clueManner> effect</clueType>.</clue>
</event>
<event KT="Analysis" Manner="Low" assertion="non-exist" id="E30">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="E28"/>
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A mutation <clueKT>showed</clueKT> <clueType>only a <clueManner>slight</clueManner> effect</clueType>.</clue>
</event>
<sentence id="S10">For all other <term id="T43" lex="arginine_mutation" sem="Other"><term id="T44" lex="arginine" sem="Amino_acid_monomer">arginine</term> mutations</term>, no differences in affinity were detectable.</sentence>
<event KT="Method" id="E31">
<type class="Mutagenesis"/>
<theme idref="T44"/>
<clue>For all other arginine <clueType>mutations</clueType>, no differences in affinity were detectable.</clue>
<comment>Artificial</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E32">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="E31"/>
<clue>For all other arginine mutations, <cluePolarity>no</cluePolarity> differences <linkTheme>in</linkTheme> <corefTheme>affinity</corefTheme> were <clueKT>detectable</clueKT>.</clue>
<comment>NO CLUETYPE</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E33">
<type class="Regulation"/>
<theme idref="E21"/>
<cause idref="E31"/>
<clue>For all other arginine mutations, <cluePolarity>no</cluePolarity> differences <linkTheme>in</linkTheme> <corefTheme>affinity</corefTheme> were <clueKT>detectable</clueKT>.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S11">The two <term id="T45" lex="mutation" sem="Other">mutations</term> <term id="T46" lex="R217A" sem="Amino_acid_monomer">R217A</term> and <term id="T47" lex="R294A" sem="Amino_acid_monomer">R294A</term> caused an increased binding efficiency for <term id="A11" sem="Other">antagonists</term> but no change in <term id="T59" sem="Other"><term id="A12" sem="Other">agonist</term> binding</term>.</sentence>
<event KT="Method" id="E34">
<type class="Mutagenesis"/>
<theme idref="T46"/>
<clue>The two <clueType>mutations</clueType> R217A and R294A caused an increased binding efficiency for antagonists but no change in agonist binding.</clue>
<comment>Artificial</comment></event>
<event KT="Method" id="E35">
<type class="Mutagenesis"/>
<theme idref="T47"/>
<clue>The two <clueType>mutations</clueType> R217A and R294A caused an increased binding efficiency for antagonists but no change in agonist binding.</clue>
<comment>Artificial</comment></event>
<event id="E36">
<type class="Binding"/>
<theme idref="A11"/>
<theme idref="T31"/>
<clue>The two mutations R217A and R294A caused an increased <clueType>binding</clueType> efficiency <linkTheme>for</linkTheme> antagonists but no change in agonist binding.</clue>
<comment>OK</comment></event>
<event id="E37">
<type class="Binding"/>
<theme idref="A12"/>
<theme idref="T31"/>
<clue>The two mutations R217A and R294A caused an increased binding efficiency for antagonists but no change in agonist <clueType>binding</clueType>.</clue>
<comment>OK</comment></event>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="E34"/>
<clue>The two mutations R217A and R294A caused an <clueType>increased</clueType> binding efficiency for antagonists but no change in agonist binding.</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="E35"/>
<clue>The two mutations R217A and R294A caused an <clueType>increased</clueType> binding efficiency for antagonists but no change in agonist binding.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E40">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="E34"/>
<clue>The two mutations R217A and R294A caused an increased binding efficiency for antagonists but <cluePolarity>no</cluePolarity> <clueType>change</clueType> <linkTheme>in</linkTheme> agonist binding.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E41">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="E35"/>
<clue>The two mutations R217A and R294A caused an increased binding efficiency for antagonists but <cluePolarity>no</cluePolarity> <clueType>change</clueType> <linkTheme>in</linkTheme> agonist binding.</clue>
</event>
<sentence id="S12">From these results, we can conclude that <term id="T48" lex="electrostatic_interaction" sem="Other">electrostatic interactions</term> of <term id="T49" lex="retinoid" sem="Organic_compound_other">retinoids</term> with the <term id="T50" lex="RAR_alpha-LBD" sem="Protein_domain_or_region"><term id="T51" lex="RAR_alpha" sem="Protein_molecule">RAR alpha</term>-LBD</term> play a significant role in <term id="T52" lex="ligand_binding" sem="Other"><term id="A13" sem="Protein_family_or_group">ligand</term> binding</term>.</sentence>
<event KT="Other" id="E42">
<type class="Binding"/>
<theme idref="T49"/>
<theme idref="T50"/>
<clue>From these results, we can conclude that electrostatic <clueType>interactions</clueType> <linkTheme>of</linkTheme> retinoids <linkTheme>with</linkTheme> the RAR alpha-LBD play a significant role in ligand binding.</clue>
<comment>NER: T50 MOD</comment></event>
<event KT="Other" id="E43">
<type class="Binding"/>
<theme idref="A13"/>
<theme idref="T51"/>
<clue>From these results, we can conclude that electrostatic interactions of retinoids with the RAR alpha-LBD play a significant role in ligand <clueType>binding</clueType>.</clue>
</event>
<event KT="Analysis" id="E44">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="E42"/>
<clue>From these results, we can <clueKT>conclude</clueKT> that electrostatic interactions of retinoids with the RAR alpha-LBD <clueType>play</clueType> a <clueType>significant role</clueType> <linkTheme>in</linkTheme> ligand binding.</clue>
</event>
<sentence id="S13">In addition, <term id="A14" sem="Other">antagonists</term> show distinctly different requirements for efficient binding, which may contribute to their interference in the <term id="A15" sem="Protein_family_or_group">ligand</term>-inducible <term id="T60" sem="Other">transactivation function</term> of <term id="T54" lex="RAR_alpha" sem="Protein_molecule">RAR alpha</term>.</sentence>
<event KT="Other" id="E45">
<type class="Binding"/>
<theme idref="A14"/>
<theme idref="T50"/>
<clue>In addition, antagonists show distinctly different requirements for efficient <clueType>binding</clueType>, which may contribute to their interference in the ligand-inducible transactivation function of RAR alpha.</clue>
<comment>NO COREFTHEME, OK</comment></event>
<event KT="Other" id="E46">
<type class="Positive_regulation"/>
<theme idref="T54"/>
<cause idref="A15"/>
<clue>In addition, antagonists show distinctly different requirements for efficient binding, which may contribute to their interference in the ligand-<linkCause>inducible</linkCause> <clueType>transactivation</clueType> function <linkTheme>of</linkTheme> RAR alpha.</clue>
</event>
<event CL="L1" KT="Analysis" id="E47">
<type class="Negative_regulation"/>
<theme idref="E46"/>
<cause idref="A14"/>
<clue>In addition, antagonists <clueKT>show</clueKT> distinctly different requirements for efficient binding, which <clueCL>may</clueCL> contribute to <linkCause>their</linkCause> <clueType>interference</clueType> in the ligand-inducible transactivation function of RAR alpha.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
